Chart 1
Prevalence of the three prescription medications most commonly used in the past month, by age group, sex and medication class, Canadians aged 18 to 79, 2016 to 2019
Note(s):
For the 18-to-39 age group, data for the treatment of high blood cholesterol and high blood pressure were too unreliable to be published (data with a coefficient of variation greater than 33.3%; suppressed because of extreme sampling variability). The prevalence of prescription medication groups was classified by the most common Anatomical Therapeutic Chemical codes: treatment of high blood pressure (C02-antihypertensives, C03-diuretics, C07-beta blocking agents, C08-calcium channel blockers, and C09-agents acting on the renin-angiotensin system), treatment of high blood cholesterol (C10-lipid modifying agents) and treatment of mood disorder (N06-psychoanaleptics).
Source(s):
Canadian Health Measures Survey (5071), Cycle 5 (2016 and 2017) and Cycle 6 (2018 and 2019).
Chart description
This is a bar clustered chart.
Treatment of mood disorder | Treatment of high blood cholesterol | Treatment of high blood pressure | |
---|---|---|---|
Age group: 18 to 39 | 8 | ||
Age group: 40 to 59 | 11 | 10 | 14 |
Age group: 60 to 79 | 13 | 34 | 42 |
Sex: Males | 7 | 15 | 18 |
Sex: Females | 14 | 9 | 14 |
Overall | 10 | 12 | 16 |
Note(s):
For the 18-to-39 age group, data for the treatment of high blood cholesterol and high blood pressure were too unreliable to be published (data with a coefficient of variation greater than 33.3%; suppressed because of extreme sampling variability). The prevalence of prescription medication groups was classified by the most common Anatomical Therapeutic Chemical codes: treatment of high blood pressure (C02-antihypertensives, C03-diuretics, C07-beta blocking agents, C08-calcium channel blockers, and C09-agents acting on the renin-angiotensin system), treatment of high blood cholesterol (C10-lipid modifying agents) and treatment of mood disorder (N06-psychoanaleptics).
Source(s):
Canadian Health Measures Survey (5071), Cycle 5 (2016 and 2017) and Cycle 6 (2018 and 2019).
- Date modified: